Morningstar Fund Report  | 17/04/2025Print

AXA Framlington Health R Acc

Performance History31/03/2025
Growth of 1,000 (GBP) Advanced Graph
AXA Framlington Health R Acc
Fund15.43.70.61.1-4.4
+/-Cat6.08.33.70.1-2.8
+/-B’mrk-2.8-2.13.1-1.6-6.3
 
Category: Sector Equity Healthcare
Category Benchmark: Morningstar Gbl Health TME ...
Key Stats
NAV
16/04/2025		 GBX 2718.00
Day Change -1.06%
Morningstar Category™ Sector Equity Healthcare
IA (formerly IMA) Sector Healthcare
ISIN GB0003506424
Fund Size (Mil)
16/04/2025		 GBP 478.48
Share Class Size (Mil)
16/04/2025		 GBP 64.93
Max Initial Charge -
Ongoing Charge
12/02/2025		  1.57%
Investment Objective: AXA Framlington Health R Acc
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Returns
Trailing Returns (GBP)16/04/2025
YTD-11.41
3 Years Annualised-2.90
5 Years Annualised4.76
10 Years Annualised4.79
12 Month Yield 0.00
Management
Manager Name
Start Date
Chris Eccles
22/01/2024
Cinney Zhang
04/07/2023
Click here to see others
Inception Date
16/10/1991

Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI World/Health Care NR GBPMorningstar Gbl Health TME NR USD
Portfolio Profile for  AXA Framlington Health R Acc31/03/2025
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock99.160.0099.16
Bond0.000.000.00
Property0.000.000.00
Cash0.940.090.84
Other0.000.000.00
Top 5 Regions%
United States70.92
Europe - ex Euro12.35
Eurozone10.84
United Kingdom5.59
Asia - Emerging0.30
Top 5 Sectors%
Healthcare98.97
Industrials1.03
Top 5 HoldingsSector%
Eli Lilly and CoHealthcareHealthcare8.54
UnitedHealth Group IncHealthcareHealthcare7.19
AstraZeneca PLCHealthcareHealthcare5.18
Merck & Co IncHealthcareHealthcare4.94
Novo Nordisk AS Class BHealthcareHealthcare4.84
Increase Decrease New since last portfolio
AXA Framlington Health R Acc
Growth Of 1000 (GBP) 31/03/2025
Fund:  AXA Framlington Health R Acc
Category:  Sector Equity Healthcare
Category Index:  Morningstar Gbl Health TME NR USD
Growth of 1,000 GBP
Annual Returns (GBP)31/03/2025
 201820192020202120222023202431/03
Price Return1.0918.2515.4815.383.680.561.12-4.40
+/- Category-1.601.22-2.005.958.343.690.15-2.79
+/- Category Index----2.83-2.133.10-1.58-6.33
% Rank in Category6346423925285679
Trailing Returns (GBP)16/04/2025
   Total Returns   +/- Category   +/- Category Index
1 Day-1.06   -1.10-0.39
1 Week2.88   2.222.74
1 Month-9.52   -2.20-2.32
3 Months-15.30   -5.42-6.70
6 Months-17.44   -5.47-5.78
YTD-11.41   -4.13-6.08
1 Year-14.77   -5.96-8.55
3 Years Annualised-2.90   0.80-2.59
5 Years Annualised4.76   1.50-0.64
10 Years Annualised4.79   -0.26-2.08
 
Category: Sector Equity Healthcare
Category Index: Morningstar Gbl Health TME NR USD
Quarterly Returns (GBP)31/03/2025
 Quarter 1Quarter 2Quarter 3Quarter 4
2025-4.40---
20249.131.00-3.62-4.81
2023-3.812.340.671.47
2022-0.21-3.514.962.58
20210.677.091.915.02
2020-7.5518.232.852.73
 
 
 
Morningstar Rating™(Relative to Category)31/03/2025
 Morningstar ReturnMorningstar RiskMorningstar Rating™
3-YearAverageBelow Average3 star
5-YearAbove AverageAverage4 star
10-YearBelow AverageAbove Average2 star
OverallAverageAverage3 star
 
Category :  Sector Equity HealthcareClick here to see our Methodology
Volatility Measurements31/03/2025
 
3-Yr Std Dev11.64 %
3-Yr Mean Return1.00 %
 
3-Yr Sharpe Ratio-0.26
 
Modern Portfolio Statistics31/03/202531/03/2025
 Standard IndexBest Fit Index
 Morningstar Gbl Health TME NR USD  Morningstar Gbl Health TME NR USD
3-Yr Beta0.930.93
3-Yr Alpha-2.52-2.52
 
Investment Style Details31/03/2025
Morningstar Style Box®
Equity Style
SizeRel to Cat
Average Mkt Cap (Mil)GBP 60947-
Market Capitalisation% of Equity
Giant36.01
Large33.00
Medium20.20
Small6.80
Micro3.99
Valuations and Growth RatesEquity PortfolioRelative to Category
Price/Prospective Earnings18.350.94
Price/Book3.780.88
Price/Sales1.780.94
Price/Cash Flow15.230.92
Dividend-Yield Factor1.350.99
 
Long-Term Projected Earnings Growth10.701.03
Historical Earnings Growth9.364.47
Sales Growth7.180.72
Cash-Flow Growth-6.522.42
Book-Value Growth5.070.67
 
Category: Sector Equity Healthcare
Asset Allocation31/03/2025
Asset Allocation
 % Long% Short% Net Assets
Stock99.160.0099.16
Bond0.000.000.00
Property0.000.000.00
Cash0.940.090.84
Other0.000.000.00
World Regions31/03/2025
 % of EquityRelative to Category
United States70.921.02
Canada0.000.00
Latin America0.000.00
United Kingdom5.591.01
Eurozone10.841.57
Europe - ex Euro12.351.03
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.00
Japan0.000.00
Australasia0.000.00
Asia - Developed0.000.00
Asia - Emerging0.300.13
 
Category: Sector Equity Healthcare
Sector Weightings31/03/2025
 % of EquityRelative to Category
HealthcareHealthcare98.971.02
IndustrialsIndustrials1.033.23
 
Category: Sector Equity Healthcare
Top 10 Holdings31/03/2025
 Portfolio NEW
Total Number of Equity Holdings47
Total Number of Bond Holdings0
Assets in Top 10 Holdings48.07
NameSectorCountry% of Assets
Eli Lilly and Co206United States8.54
UnitedHealth Group Inc206United States7.19
AstraZeneca PLC206United Kingdom5.18
Merck & Co Inc206United States4.94
Novo Nordisk AS Class B206Denmark4.84
Thermo Fisher Scientific Inc206United States4.52
Becton Dickinson & Co206United States3.79
Intuitive Surgical Inc206United States3.19
Boston Scientific Corp206United States2.96
CVS Health Corp206United States2.92
 
Increase Decrease New since last portfolio
Category: Sector Equity Healthcare
 
Management
Name of CompanyAXA Investment Managers UK Ltd
Phone44 20 7003 2345
Websitewww.axa-im.com
Address22 Bishopsgate
 London   EC2N 4BQ
 United Kingdom
DomicileUnited Kingdom
Legal StructureUnit Trust
UCITSYes
Inception Date16/10/1991
Fund Advisor(s)
AXA Investment Managers UK Ltd
Fund ManagerChris Eccles
Manager Start Date22/01/2024
Career Start Year2011
Education
University of Oxford, M.A.
 
Biography
Chris Eccles is a research analyst who specialises in testing and regulatory affairs. He researches stocks globally and focuses on the Healthcare sector. Chris joined Impax in March 2019. He started working in the financial industry in 2011 as a research analyst at Morgan Stanley where he focused on European large-cap pharmaceuticals. In 2014, he became a partner at the hedge fund Kola Capital where he worked as a global equities analyst for three years before moving to Stifel in 2017 to work as a Healthcare Specialist. Chris achieved an MA (Oxon) Physiological Sciences First Class Honours, from the University of Oxford.
Fund ManagerCinney Zhang
Manager Start Date04/07/2023
Fund ManagerCatherine Tennyson
Manager Start Date29/03/2024
Fees and Expenses
Sales Charges (Maximum) 
Max Initial Chargen/a
Max Exit Charge*n/a
Annual Charges
Max Annual Management Charge1.50%
Ongoing Charge1.57%
Purchase Details
Minimum Investments
Initial1000  GBP
Additional100  GBP
Savings50  GBP
Tax Free Savings Schemes
ISAsYes